Patents by Inventor Ilaria Lampronti

Ilaria Lampronti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isoxazole derivatives as inducers of fetal hemoglobin in erythroid precursor cells from beta-thalassemic patients
    Patent number: 11077116
    Abstract: The invention refers to the use of isoxazole derivatives to prepare medicament able to induce fetal hemoglobin (HbF) synthesis in ?-thalassemia and sickle cell disease (SCD) patients.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: August 3, 2021
    Assignee: RARE PARTNERS SRL
    Inventors: Ilaria Lampronti, Roberto Gambari, Daniele Simoni
  • ISOXAZOLE DERIVATIVES AS INDUCERS OF FETAL HEMOGLOBIN IN ERYTHROID PRECURSOR CELLS FROM BETA-THALASSEMIC PATIENTS
    Publication number: 20200206234
    Abstract: The invention refers to the use of isoxazole derivatives to prepare medicament able to induce fetal hemoglobin (HbF) synthesis in ?-thalassemia and sickle cell disease (SCD) patients.
    Type: Application
    Filed: July 13, 2018
    Publication date: July 2, 2020
    Applicant: RARE PARTNERS SRL
    Inventors: Ilaria Lampronti, Roberto Gambari, Daniele Simoni
  • Use of angelicin and of its structural analogues for the treatment of thalassemia
    Patent number: 7572827
    Abstract: The use of angelicin and its structural analogues for the preparation of a medicament for the therapeutic treatment of beta-thalassaemia is described. A structural analogue which is particularly preferred for this purpose is bergapten.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: August 11, 2009
    Assignees: Universita' Degli Studi Di Ferrara, Associazione Veneta Per La Lotta Alla Talassemia
    Inventors: Nicoletta Bianchi, Monica Borgatti, Roberto Gambari, Ilaria Lampronti
  • Use of angelicin and of its structural analogues for the treatment of thalassemia
    Publication number: 20060111433
    Abstract: The use of angelicin and its structural analogues for the preparation of a medicament for the therapeutic treatment of beta-thalassaemia is described. A structural analogue which is particularly preferred for this purpose is bergapten.
    Type: Application
    Filed: July 30, 2003
    Publication date: May 25, 2006
    Inventors: Nicoletta Bianchi, Monica Borgatti, Roberto Gambari, Ilaria Lampronti